CLINICA 100 TOP 10: Medtronic
This article was originally published in Clinica
Climbing up one position to the No 2 spot in this year’s Clinica 100 is Medtronic. The company benefited from its $43bn merger with Covidien – the biggest M&A deal in medtech history – which closed at the end of January 2015. Medtronic’s fiscal 2015 ended April 24, 2015*, so the financial figures for that year included Covidien’s sales in the fourth quarter.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.